These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9834251)

  • 41. Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Richards SJ; Dickinson AJ; Cullen MJ; Griffin M; Munir T; McKinley C; Mitchell LD; Newton DJ; Arnold L; Hill A; Hillmen P
    Br J Haematol; 2020 Jun; 189(5):954-966. PubMed ID: 32103498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
    Battiwalla M; Hepgur M; Pan D; McCarthy PL; Ahluwalia MS; Camacho SH; Starostik P; Wallace PK
    Cytometry B Clin Cytom; 2010 Sep; 78(5):348-56. PubMed ID: 20533383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced cytotoxicity of rituximab following genetic and biochemical disruption of glycosylphosphatidylinositol anchored proteins.
    Nagajothi N; Matsui WH; Mukhina GL; Brodsky RA
    Leuk Lymphoma; 2004 Apr; 45(4):795-9. PubMed ID: 15160958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
    Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
    Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.
    Meletis J; Michali E; Samarkos M; Konstantopoulos K; Meletis C; Terpos E; Tsimberidou A; Chandrinou E; Viniou N; Rombos Y; Pangalis GA; Yataganas X; Loukopoulos D
    Leuk Lymphoma; 1997 Dec; 28(1-2):177-82. PubMed ID: 9498717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria.
    Hernández-Campo PM; Almeida J; Sánchez ML; Malvezzi M; Orfao A
    Cytometry B Clin Cytom; 2006 Mar; 70(2):71-81. PubMed ID: 16493662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis.
    Shibuya K; Ninomiya H; Muraki Y; Nagasawa T; Abe T
    Int J Hematol; 1993 Aug; 58(1-2):15-20. PubMed ID: 7693026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
    Astori C; Bonfichi M; Pagnucco G; Bernasconi P; Lazzarino M; Orlandi E; Bernasconi C
    Br J Haematol; 1997 Jun; 97(3):586-8. PubMed ID: 9207404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
    Nilsson B; Hagström U; Englund A; Säfwenberg J
    Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.
    Sica M; Rondelli T; Ricci P; De Angioletti M; Risitano AM; Notaro R
    J Hematol Oncol; 2017 Jun; 10(1):126. PubMed ID: 28629435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PNH revisited: Clinical profile, laboratory diagnosis and follow-up.
    Gupta PK; Charan VD; Kumar H
    Indian J Pathol Microbiol; 2009; 52(1):38-41. PubMed ID: 19136777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.
    Richaud-Patin Y; Pérez-Romano B; Carrillo-Maravilla E; Rodriguez AB; Simon AJ; Cabiedes J; Jakez-Ocampo J; Llorente L; Ruiz-Argüelles A
    Immunol Lett; 2003 Aug; 88(2):95-9. PubMed ID: 12880676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
    Sun X; Funk CD; Deng C; Sahu A; Lambris JD; Song WC
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):628-33. PubMed ID: 9892684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia.
    Gwamaka M; Fried M; Domingo G; Duffy PE
    Malar J; 2011 Dec; 10():386. PubMed ID: 22206234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Lin LI; Chen YC; Lin JK
    Hematology; 1997; 2(5):399-406. PubMed ID: 27405407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitive and accurate identification of PNH clones based on ICCS/ESCCA PNH Consensus Guidelines-A summary.
    Illingworth AJ; Marinov I; Sutherland DR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():73-81. PubMed ID: 31069981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Zhang L; Chen JY; Kerr C; Cobb BA; Maciejewski JP; Lin F
    Leukemia; 2021 Apr; 35(4):1176-1187. PubMed ID: 32814838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
    Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
    Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow cytometric analysis of erythrocytes in paroxysmal nocturnal hemoglobinuria reveals superiority of CD59 as a diagnostic marker compared to CD55.
    Tembhare P; Ramani M; Syed K; Gupta AD
    Indian J Pathol Microbiol; 2010; 53(4):699-703. PubMed ID: 21045396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.